19 results on '"Oshima, Junko"'
Search Results
2. Rapid emergence of transcriptional heterogeneity upon molecular stress predisposes cells to two distinct states of senescence.
- Author
-
Burnaevskiy, Nikolay, Oshima, Junko, and Mendenhall, Alexander R.
- Subjects
AGING ,TISSUE remodeling ,COHERENT states ,GENE expression ,HETEROGENEITY ,CELL populations - Abstract
Slowing aging can reduce the risk of chronic diseases. In particular, eliminating senescent cells is a promising approach to slow aging. Previous studies found that both cells from older animals and senescent cells have noisy gene expression. Here, we performed a large-scale single-cell RNA-sequencing time course to understand how transcriptional heterogeneity develops among senescent cells. We found that cells experiencing senescence-inducing oxidative stress rapidly adopt one of two major transcriptional states. One senescent cell state is associated with stress response, and the other is associated with tissue remodeling. We did not observe increased stochastic gene expression. This data is consistent with the idea that reproducible, limited, distinct, and coherent transcriptional states exist in senescent cell populations. These physiologically distinct senescent cell subtypes may each affect the aging process in unique ways and constitute a source of heterogeneity in aging. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
3. SMAD4 mutations and cross-talk between TGF-β/IFNγ signaling accelerate rates of DNA damage and cellular senescence, resulting in a segmental progeroid syndrome—the Myhre syndrome.
- Author
-
Kandhaya-Pillai, Renuka, Hou, Deyin, Zhang, Jiaming, Yang, Xiaomeng, Compoginis, Goli, Mori, Takayasu, Tchkonia, Tamara, Martin, George M., Hisama, Fuki M., Kirkland, James L., and Oshima, Junko
- Subjects
CELLULAR aging ,DNA damage ,GENETIC variation ,MTOR protein ,SMAD proteins - Abstract
SMAD4 encodes a member of the SMAD family of proteins involved in the TGF-β signaling pathway. Potentially heritable, autosomal dominant, gain-of-function heterozygous variants of SMAD4 cause a rare developmental disorder, the Myhre syndrome, which is associated with a wide range of developmental and post-developmental phenotypes that we now characterize as a novel segmental progeroid syndrome. Whole-exome sequencing of a patient referred to our International Registry of Werner Syndrome revealed a heterozygous p.Arg496Cys variant of the SMAD4 gene. To investigate the role of SMAD4 mutations in accelerated senescence, we generated cellular models overexpressing either wild-type SMAD4 or mutant SMAD4-R496C in normal skin fibroblasts. We found that cells expressing the SMAD4-R496C mutant exhibited decreased proliferation and elevated expression of cellular senescence and inflammatory markers, including IL-6, IFNγ, and a TGF-β target gene, PAI-1. Here we show that transient exposure to TGF-β, an inflammatory cytokine, followed by chronic IFNγ stimulation, accelerated rates of senescence that were associated with increased DNA damage foci and SMAD4 expression. TGF-β, IFNγ, or combinations of both were not sufficient to reduce proliferation rates of fibroblasts. In contrast, TGF-β alone was able to induce preadipocyte senescence via induction of the mTOR protein. The mTOR inhibitor rapamycin mitigated TGF-β-induced expression of p21, p16, and DNA damage foci and improved replicative potential of preadipocytes, supporting the cell-specific response to this cytokine. These findings collectively suggest that persistent DNA damage and cross-talk between TGF-β/IFNγ pathways contribute to a series of molecular events leading to cellular senescence and a segmental progeroid syndrome. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
4. Truncated prelamin A expression in HGPS-like patients: a transcriptional study.
- Author
-
Barthélémy, Florian, Navarro, Claire, Fayek, Racha, Da Silva, Nathalie, Roll, Patrice, Sigaudy, Sabine, Oshima, Junko, Bonne, Gisèle, Papadopoulou-Legbelou, Kyriaki, Evangeliou, Athanasios E, Spilioti, Martha, Lemerrer, Martine, Wevers, Ron A, Morava, Eva, Robaglia-Schlupp, Andrée, Lévy, Nicolas, Bartoli, Marc, and De Sandre-Giovannoli, Annachiara
- Subjects
PROGERIA ,PREMATURE aging (Medicine) ,GENETIC disorders ,NUCLEAR deformation ,DNA damage - Abstract
Premature aging syndromes are rare genetic disorders mimicking clinical and molecular features of aging. A recently identified group of premature aging syndromes is linked to mutation of the LMNA gene encoding lamins A and C, and is associated with nuclear deformation and dysfunction. Hutchinson-Gilford progeria syndrome (HGPS) was the first premature aging syndrome linked to LMNA mutation and its molecular bases have been deeply investigated. It is due to a recurrent de novo mutation leading to aberrant splicing and the production of a truncated and toxic nuclear lamin A precursor (prelamin AΔ50), also called progerin. In this work and based on the literature data, we propose to distinguish two main groups of premature aging laminopathies: (1) HGPS and HGP-like syndromes, which share clinical features due to hampered processing and intranuclear toxic accumulation of prelamin A isoforms; and (2) APS (atypical progeria syndromes), due to dominant or recessive missense mutations affecting lamins A and C. Among HGPS-like patients, several deleted prelamin A transcripts (prelamin AΔ50, AΔ35 and AΔ90) have been described. The purpose of this work was to characterize those transcripts in eight patients affected with HGP-like rare syndromes. When fibroblasts were available, the relationships between the presence and ratios of these transcripts and other parameters were studied, aiming to increase our understanding of genotype-phenotype relationships in HGPS-like patients. Altogether our results evidence that progerin accumulation is the major pathogenetic mechanism responsible for HGP-like syndromes due to mutations near the donor splice site of exon 11. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
5. Uncommon cause of cirrhosis-A case of Werner syndrome with a novel WRN mutation.
- Author
-
Amalnath, S., Sargolzaeiaval, Forough, Oshima, Junko, and Baskar, Dipti
- Abstract
Werner syndrome is a rare progeroid syndrome caused by the WRN gene mutation. It is characterized by a general appearance of premature aging, diabetes mellitus, and atherosclerosis, and an increased risk of malignancies. We report a patient who presented with hematemesis due to cirrhosis of liver and was subsequently diagnosed with Werner syndrome. Further genetic analysis showed a novel mutation in the WRN gene which has not previously been reported. Werner syndrome should be considered for the cases of liver cirrhosis when accompanied by the features of accelerated aging. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
6. LCR-initiated rearrangements at the IDS locus, completed with Alu-mediated recombination or non-homologous end joining.
- Author
-
Oshima, Junko, Lee, Jennifer A, Breman, Amy M, Fernandes, Priscilla H, Babovic-Vuksanovic, Dusica, Ward, Patricia A, Wolfe, Lynne A, Eng, Christine M, and del Gaudio, Daniela
- Subjects
- *
MUCOPOLYSACCHARIDOSIS , *GENETIC mutation , *ETIOLOGY of diseases , *GENETIC code , *DISEASE relapse , *LYSOSOMAL storage diseases - Abstract
Mucopolysaccharidosis type II (MPS II) is caused by mutations in the IDS gene, which encodes the lysosomal enzyme iduronate-2-sulfatase. In ∼20% of MPS II patients the disorder is caused by gross IDS structural rearrangements. We identified two male cases harboring complex rearrangements involving the IDS gene and the nearby pseudogene, IDSP1, which has been annotated as a low-copy repeat (LCR). In both cases the rearrangement included a partial deletion of IDS and an inverted insertion of the neighboring region. In silico analyses revealed the presence of repetitive elements as well as LCRs at the junctions of rearrangements. Our models illustrate two alternative consequences of rearrangements initiated by non-allelic homologous recombination of LCRs: resolution by a second recombination event (that is, Alu-mediated recombination), or resolution by non-homologous end joining repair. These complex rearrangements have the potential to be recurrent and may be present among those MSP II cases with previously uncharacterized aberrations involving IDS. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
7. Regional genomic instability predisposes to complex dystrophin gene rearrangements.
- Author
-
Oshima, Junko, Magner, Daniel B., Lee, Jennifer A., Breman, Amy M., Schmitt, Eric S., White, Lisa D., Crowe, Carol A., Merrill, Michelle, Jayakar, Parul, Rajadhyaksha, Aparna, Eng, Christine M., and del Gaudio, Daniela
- Subjects
- *
GENETIC mutation , *MEMBRANE proteins , *GENETICS , *GENES , *DYSTROPHIN genes , *DUCHENNE muscular dystrophy - Abstract
Mutations in the dystrophin gene ( DMD) cause Duchenne and Becker muscular dystrophies and the majority of cases are due to DMD gene rearrangements. Despite the high incidence of these aberrations, little is known about their causative molecular mechanism(s). We examined 792 DMD/BMD clinical samples by oligonucleotide array-CGH and report on the junction sequence analysis of 15 unique deletion cases and three complex intragenic rearrangements to elucidate potential underlying mechanism(s). Furthermore, we present three cases with intergenic rearrangements involving DMD and neighboring loci. The cases with intragenic rearrangements include an inversion with flanking deleted sequences; a duplicated segment inserted in direct orientation into a deleted region; and a splicing mutation adjacent to a deletion. Bioinformatic analysis demonstrated that 7 of 12 breakpoints combined among 3 complex cases aligned with repetitive sequences, as compared to 4 of 30 breakpoints for the 15 deletion cases. Moreover, the inversion/deletion case may involve a stem-loop structure that has contributed to the initiation of this rearrangement. For the duplication/deletion and splicing mutation/deletion cases, the presence of the first mutation, either a duplication or point mutation, may have elicited the deletion events in an attempt to correct preexisting mutations. While NHEJ is one potential mechanism for these complex rearrangements, the highly complex junction sequence of the inversion/deletion case suggests the involvement of a replication-based mechanism. Our results support the notion that regional genomic instability, aided by the presence of repetitive elements, a stem-loop structure, and possibly preexisting mutations, may elicit complex rearrangements of the DMD gene. [ABSTRACT FROM AUTHOR]
- Published
- 2009
- Full Text
- View/download PDF
8. The clinical characteristics of Werner syndrome: molecular and biochemical diagnosis.
- Author
-
Muftuoglu, Meltem, Oshima, Junko, von Kobbe, Cayetano, Wen-Hsing Cheng, Leistritz, Dru F., and Bohr, Vilhelm A.
- Subjects
- *
WERNER'S syndrome , *PROGERIA , *DNA repair , *DEVELOPMENTAL biology , *NUCLEOTIDE sequence - Abstract
Werner syndrome (WS) is an adult onset segmental progeroid syndrome caused by mutations in the WRN gene. The WRN gene encodes a 180 kDa nuclear protein that possesses helicase and exonuclease activities. The absence of WRN protein leads to abnormalities in various DNA metabolic pathways such as DNA repair, replication and telomere maintenance. Individuals with WS generally develop normally until the third decade of life, when premature aging phenotypes and a series of age-related disorders begin to manifest. In Japan, where a founder effect has been described, the frequency of Werner heterozygotes appears to be as high as 1/180 in the general population. Due to the relatively non-specific nature of the symptoms and the lack of awareness of the condition, this disease may be under-diagnosed in other parts of the world. Genetic counseling of WS patients follows the path of other autosomal recessive disorders, with special attention needed for cancer surveillance in relatives. Molecular diagnosis of WS is made by nucleotide sequencing and, in some cases, protein analysis. It is also of potential interest to measure WRN activities in WS patients. More than 50 different disease-causing mutations in the WRN gene have been identified in WS patients from all over the world. All but one of these cases has mutations that result in the premature termination of the protein. Here we describe the clinical, molecular and biochemical characteristics of WS for use by medical professionals in a health care setting. Additional information is available through the International Registry of WS (). [ABSTRACT FROM AUTHOR]
- Published
- 2008
- Full Text
- View/download PDF
9. Correction of cellular phenotypes of Hutchinson-Gilford Progeria cells by RNA interference.
- Author
-
Shurong Huang, Lishan Chen, Libina, Nataliya, Janes, Joel, Martin, George M., Campisi, Judith, and Oshima, Junko
- Subjects
PROGERIA ,RNA ,CORONARY arteries ,ATHEROSCLEROSIS ,GENE therapy ,GENETIC mutation - Abstract
The great majority of cases of the Hutchinson-Gilford progeroid syndrome (HGPS) (“Progeria of Childhood‘’) are caused by a single nucleotide mutation (1824 C->T) in the LMNA gene which encodes lamin A and C, nuclear intermediate filaments that are important components of the nuclear lamina. The resultant mutant protein (Δ50 lamin A) is thought to act in a dominant fashion. We exploited RNA interference technology to suppress Δ50 lamin A expression, with the long range goal of intervening in the pathogenesis of the coronary artery atherosclerosis that typically leads to the death of HGPS patients. Short hairpin RNA (shRNA) constructs were designed to target the mutated pre-spliced or mature LMNA mRNAs, and were expressed in HGPS fibroblasts carrying the 1824 C->T mutations using lentiviruses. One of the shRNAs targeted to the mutated mRNA reduced the expression levels of Δ50 lamin A to 26% or lower. The reduced expression was associated with amelioration of abnormal nuclear morphology, improvement of proliferative potential, and reduction in the numbers of senescent cells. These findings provide a rationale for potential gene therapy. [ABSTRACT FROM AUTHOR]
- Published
- 2005
- Full Text
- View/download PDF
10. Transfection of neuroprogenitor cells with iron nanoparticles for magnetic resonance imaging tracking: cell viability, differentiation, and intracellular localization.
- Author
-
Miyoshi, Sosuke, Flexman, Jennifer A, Cross, Donna J, Maravilla, Kenneth R, Kim, Yongmin, Anzai, Yoshimi, Oshima, Junko, and Minoshima, Satoshi
- Abstract
Purpose: Magnetic resonance imaging (MRI) can track labeled cells in the brain. The use of hemagglutinating virus of Japan envelopes (HVJ-Es) to effectively introduce the contrast agent to neural progenitor cells (NPCs) is limited to date despite their high NPC affinity.Procedures: HVJ-Es and Lipofectamine 2000 were compared as transfection vehicles of superparamagnetic iron oxide (SPIO). Labeled NPCs were examined for iron content, MRI signal change, and fundamental cell characteristics. Prussian Blue staining was used after differentiation to determine SPIO localization.Results: HVJ-Es transfected up to 12.5 +/- 8.8 times more SPIO into NPCs. HVJ-Es do not affect cell viability or differentiation capability. Superparamagnetic iron oxide was disseminated in both the soma and neurites.Conclusions: These findings indicate that HVJ-Es are an effective vehicle for SPIO transfection of NPCs. The intracellular localization after differentiation raises the question as to the capability of MRI to distinguish cell migration from axonal or dendritic growth in vivo. [ABSTRACT FROM AUTHOR]- Published
- 2005
- Full Text
- View/download PDF
11. Lessons from human progeroid syndromes.
- Author
-
Martin, George M. and Oshima, Junko
- Subjects
- *
AGING , *GENETIC mutation , *WERNER'S syndrome , *GENES , *GENETICS - Abstract
Reports that a number of human genes have been identified in which mutations can lead to the acceleration of aging. How studies of these genes and their protein products may lead to a clearer understanding of aging; Mention of age-related diseases, including Alzheimer's disease; Explanation of Werner syndrome, which leads to symptoms such as cataracts, osteoporosis and atherosclerosis; Opinion that senescence results from the waning of the force of natural selection.
- Published
- 2000
- Full Text
- View/download PDF
12. An apoptosis-inducing genotoxin differentiates heterozygotic carriers for Werner helicase mutations from wild-type and homozygous mutants.
- Author
-
Ogburn, Charles E., Oshima, Junko, Poot, Martin, Chen, R., Hunt, Kristin E., Gollahon, Katherine A., Rabinovitch, Peter S., and Martin, G. M.
- Abstract
Immortalized B lymphocytes from Werner syndrome subjects are shown to be hypersensitive to 4-nitroquinoline-1-oxide (4NQO), supporting earlier work on T lymphocytes. We also show that B cell lines from clinically normal heterozygous carriers exhibit sensitivities to this genotoxic agent, which are intermediate to those of wild-type and homozygous mutants. 4NQO is shown to induce an apoptotic response. These data encourage research on DNA repair with such cell lines and raise the question of an enhanced sensitivity of the relatively prevalent heterozygous carriers to certain environmental genotoxic agents. [ABSTRACT FROM AUTHOR]
- Published
- 1997
- Full Text
- View/download PDF
13. Evidence against DNA polymerase β as a candidate gene for Werner syndrome.
- Author
-
Chang, Ming, Burmer, Glenna, Sweasy, Joann, Loeb, Lawrence, Edelhoff, Susanne, Disteche, Christine, Yu, Chang-En, Anderson, Leojean, Oshima, Junko, Nakura, Jun, Miki, Tetsuro, Kamino, Kouzin, Ogihara, Toshio, Schellenberg, Gerard, and Martin, George
- Abstract
Werner syndrome (WS) is a rare autosomal recessive disorder of humans characterized by the premature onset and accelerated rate of development of several major age-related disorders. An aberration in DNA replication or repair is suggested by the evidence of genome instability. Since the structural gene for DNA polymerase β maps within the region of the WS mutation on the short arm of chromosome 8 and is involved in both DNA repair and DNA replication, we evaluated its candidacy as the WS gene. Several independent lines of evidence did not support that hypothesis: (1) activity gels showed normal enzyme activity and electrophoretic mobility; (2) nucleotide sequence analysis of the entire coding region failed to reveal mutations (although indicated mistakes in the published sequence); (3) single-strand conformation polymorphism (SSCP) and heteroduplex analyses failed to reveal evidence of mutations in the promoter region; (4) a newly discerned polymorphism failed to reveal evidence of homozygosity by descent in a consanguineous patient; and 5) fluorescence in situ hybridization (FISH) analysis placed the DNA polymerase β gene centromeric to D8S135 at 8p11.2 and thus beyond the region of peak LOD scores for WS. [ABSTRACT FROM AUTHOR]
- Published
- 1994
- Full Text
- View/download PDF
14. The Werner syndrome protein is a DNA helicase.
- Author
-
Gray, Matthew D., Shen, Jiang-Cheng, Kamath-Loeb, Ashwini S., Blank, A., Sopher, Bryce L., Martin, George M., Oshima, Junko, and Loeb, Lawrence A.
- Published
- 1997
- Full Text
- View/download PDF
15. The premature ageing syndrome protein, WRN, is a 3′→5′ exonuclease.
- Author
-
Huang, Shurong, Li, Baomin, Gray, Matthew D., Oshima, Junko, Mian, I. Saira, and Campisi, Judith
- Subjects
WERNER'S syndrome ,EXONUCLEASES ,ENDONUCLEASES ,GENETICS - Abstract
Tests the prediction that WRN, the gene defective in Werner syndrome, is an exonuclease. Use of tagged recombinant wild-type and mutant WRN proteins; Finding that WRN is indeed an endonuclease, which resides in the N terminus; Difference from other human RecQ-like helicases; Possible explanation for the differences between Werner syndrome and Bloom's syndrome.
- Published
- 1998
- Full Text
- View/download PDF
16. Ageing: Dietary protection for genes.
- Author
-
Oshima, Junko and Martin, George M.
- Published
- 2016
- Full Text
- View/download PDF
17. Werner syndrome through the lens of tissue and tumour genomics.
- Author
-
Tokita, Mari, Kennedy, Scott R., Risques, Rosa Ana, Chun, Stephen G., Pritchard, Colin, Oshima, Junko, Liu, Yan, Bryant-Greenwood, Peter K., Welcsh, Piri, and Monnat, Raymond J.
- Published
- 2016
- Full Text
- View/download PDF
18. Clinical utility gene card for: Werner Syndrome - Update 2014.
- Author
-
Hisama, Fuki M, Kubisch, Christian, Martin, George M, and Oshima, Junko
- Subjects
WERNER'S syndrome ,GENETIC disorder diagnosis ,PROGERIA ,PREMATURE aging (Medicine) ,EXONS (Genetics) ,GENETICS ,DIAGNOSIS - Abstract
The article presents a study which examines a clinical utility gene card for the diagnosis of Werner disease. Topics of the study include the analysis of mutations of exon as well as genomic rearrangement, the validation of assessing for nucleotide and proteins sequencing and the estimated frequency of the disease. The diagnostic features of Werner's syndrome disease are also presented.
- Published
- 2015
- Full Text
- View/download PDF
19. Clinical utility gene card for: Werner syndrome.
- Author
-
Hisama, Fuki M, Kubisch, Christian, Martin, George M, and Oshima, Junko
- Subjects
WERNER'S syndrome ,GENETIC testing ,PREMATURE aging (Medicine) ,DIABETES ,GENETIC disorder diagnosis - Abstract
The article offers information on genetic testing for the diagnosis of Werner syndrome, an adult-onset disorder. It informs that the earliest symptom is the lack of a growth spurt in adolescence. It reports that gene testing can be vital in patients for confirming the autosomal recessive inheritance. Werner syndrome can also be diagnosed clinically in many ways including testing for diabetes mellitus and taking a family pedigree.
- Published
- 2012
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.